Lsv Asset Management’s Regeneron Pharmaceuticals Position
Does Lsv Asset Management own Regeneron Pharmaceuticals (REGN)? Yes — 196.3K shares worth $152M (+0.33% of its 13F portfolio) as of Q1 2026, up from 166.5K shares the prior filed quarter.
Position Value
$152M
Q1 2026
Shares
196.3K
% of Portfolio
+0.33%
Quarters Held
20
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 196.3K | $152M | +0.33% |
| Q4 2025 | 166.5K | $129M | +0.28% |
| Q3 2025 | 55.6K | $31M | +0.07% |
| Q1 2025 | 8 | $5,000 | 0.00% |
| Q4 2024 | 4 | $3,000 | 0.00% |
| Q1 2023 | 49.4K | $41M | +0.09% |
| Q4 2022 | 52.1K | $38M | +0.08% |
| Q3 2022 | 53.8K | $37M | +0.09% |
| Q2 2022 | 57.4K | $34M | +0.07% |
| Q1 2022 | 191.7K | $134M | +0.25% |
| Q4 2021 | 200.3K | $126M | +0.22% |
| Q3 2021 | 209.9K | $127M | +0.23% |
| Q2 2021 | 236.4K | $132M | +0.22% |
| Q1 2021 | 252.0K | $119M | +0.20% |
| Q4 2020 | 263.7K | $127M | +0.23% |
| Q3 2020 | 298.6K | $167M | +0.34% |
| Q2 2020 | 321.6K | $201M | +0.42% |
| Q1 2020 | 385.1K | $188M | +0.45% |
| Q4 2019 | 301.3K | $113M | +0.18% |
| Q3 2019 | 26.0K | $7M | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of REGN.